Lisdexamfetamine (Vyvanse): Uses, Dosage, Side Effects & Safety

What It's Used For

Vyvanse is a once-daily stimulant used for ADHD and (in adults) moderate to severe binge eating disorder. It’s designed for morning dosing and usually covers most of the day. This is not a weight-loss drug, and it’s not meant to be taken “as needed” like a rescue med—its best use is consistent, intentional treatment with monitoring.

Primary Indications

ADHD (ages 6+ and adults): Improves attention, reduces impulsivity, and helps with follow-throughBinge Eating Disorder (adults): Helps reduce binge frequency and loss-of-control eating (stop if it doesn’t help)

Off-Label Uses

Executive dysfunction when ADHD symptoms are the main driver (clinician-dependent, diagnosis-driven)

How Fast It Works

Vyvanse is a prodrug—your body converts it to dextroamphetamine—so it tends to feel smoother and longer than many short-acting stimulants.

Morning dosing

Designed to be taken once daily in the morning

~1–2 hours

Many people start noticing effects (varies person to person)

~3–5 hours

Strongest effect window for many people (matches peak active metabolite timing)

8–14 hours

Typical duration of action range

High-fat meal

Can delay peak timing by ~1 hour, but you can still take it with or without food

Safe Discontinuation

Vyvanse doesn’t usually require a long medical taper the way benzodiazepines do, but abruptly stopping after high doses or long-term use can still hit hard—think fatigue, low mood, irritability, and a big rebound of ADHD symptoms. The plan should match the real-world situation: dose, duration, side effects, and misuse risk.

Key Points

If stopping because of dangerous side effects (psychosis/mania, severe cardiovascular symptoms), stop and get urgent medical guidance.
Common “stimulant crash” symptoms after stopping: sleepiness, depressed mood, increased appetite, low motivation, and brain fog.
If you’ve been on higher doses for a long time, some clinicians prefer a brief step-down to reduce the crash (especially if mood is fragile).
If misuse has been part of the picture, stopping should include safety planning and support (and sometimes a more structured program).
Don’t replace Vyvanse with escalating caffeine or other stimulants—this often worsens anxiety, sleep, and heart strain.

Dosing Information

Adult Dosing

adhd initial: 30 mg PO once daily in the morning

adhd titration: Increase by 10 mg or 20 mg at weekly intervals until optimal response

adhd max: 70 mg/day

binge eating initial: 30 mg PO once daily in the morning

binge eating titration: Increase by 20 mg at weekly intervals toward a target of 50 to 70 mg once daily

binge eating max: 70 mg/day; discontinue if binge eating does not improve

renal impairment: GFR 15 to <30 mL/min/1.73 m2: max 50 mg/day. GFR <15 or ESRD on hemodialysis: max 30 mg/day (not dialyzable). GFR ≥30: no manufacturer adjustment provided.

hepatic: No manufacturer dose adjustment provided.

older adult: Use adult dosing but start at the low end of the range and titrate cautiously due to higher sensitivity to stimulant side effects.

Simple Explanation

It’s once daily and meant for the morning. If it’s causing insomnia, irritability, appetite collapse, or heart symptoms, the dose or plan needs adjustment—pushing higher usually makes those problems worse.

Available Formulations

Capsules (Vyvanse): 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg
Capsules (Generic lisdexamfetamine): 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg
Chewable tablets (Vyvanse): 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
Chewable tablets (Generic lisdexamfetamine): 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
Oral solution (lisdexamfetamine; example: Arynta): FDA approved June 2025; availability may vary by market and supply

Critical Safety Information

Stimulants can raise blood pressure/heart rate and carry abuse and dependence risk. Screen for heart risk and misuse risk before starting.

→Take it in the morning. Afternoon dosing is a predictable insomnia trap.
→Tell your clinician about personal or family history of sudden cardiac death, arrhythmias, structural heart problems, fainting, or exertional chest pain.
→If you have bipolar disorder or a history of psychosis/mania, this needs extra caution and close monitoring.
→Don’t share this medication. Store it securely. Diversion risk is real.
→If fingers/toes turn white/blue, feel numb, or get painful—report it.
→If you feel suddenly paranoid, hear/see things, or feel “amped into mania,” stop and contact your prescriber urgently.

Side Effects

Most common: decreased appetite, insomnia, dry mouth, jitteriness, irritability, and GI upset. Side effects often show up early or after dose increases, and sometimes improve with time, dose adjustment, or better timing/meal planning.

Common Things People Notice

Decreased appetite (very common)
Insomnia (common, especially if taken late or dose is too high)
Dry mouth
Jittery/amped feeling
Irritability or moodiness (often worse when underfed or sleep-deprived)
Nausea or constipation/diarrhea

Common Side Effects

Adults: 8% to 27%; Children/Adolescents: 34% to 39%

Decreased appetite— This is the classic stimulant side effect. If you don’t plan food, you can end up shaky, irritable, headachy, and sleepless. A high-protein breakfast and a scheduled lunch (even if it’s small) can make a big difference.

13% to 27%

Insomnia— Usually a timing or dose issue. Morning-only dosing is standard. If sleep is consistently worse, the plan needs adjusting—because untreated insomnia will destroy the benefits.

Adults: 26% to 36%

Dry mouth— Hydration helps, and sugar-free gum/candy can help. If dry mouth is intense, it can increase dental risk over time—don’t ignore it.

Adults: Anxiety 5% to 6%; Jitteriness 4% to 6%; Restlessness 2% to 3%

Anxiety / jitteriness / restlessness— Sometimes this means the dose is too high, caffeine is stacking, sleep is poor, or baseline anxiety isn’t being treated. “More stimulant” usually makes this worse, not better.

Children: 10% (reported); Adults: variable

Irritability— Irritability can be a dose/timing issue, a hunger issue, a rebound issue as it wears off, or a clue that mood/anxiety needs attention.

Nausea 6% to 7%; Constipation (adults) 6%; Diarrhea (adults) 4% to 7%

GI upset (nausea/constipation/diarrhea)— Often improves with food timing, hydration, and dose adjustments. If it’s persistent or severe, reassess.

Adults: Increased BP 3%; Increased HR 2% to 7%; Palpitations 2%

Increased heart rate / blood pressure / palpitations— This is why we check vitals. If you’re feeling chest pain, fainting, or severe shortness of breath, that’s urgent.

Serious side effects

Serious cardiovascular events (rare): myocardial infarction, stroke, sudden cardiac death—risk is higher with underlying heart disease, higher doses, dehydration, or extreme exertion
New or worsening psychosis/mania: paranoia, hallucinations, delusional thinking, or manic escalation (can happen even without prior history, but risk is higher with vulnerability)
Serotonin syndrome (rare but dangerous): agitation, sweating, diarrhea, tremor, fever, muscle rigidity—especially with serotonergic meds or certain drug interactions
Peripheral vasculopathy (including Raynaud): painful, cold, numb, or color-changing fingers/toes; rarely digital ulceration
Misuse, abuse, and dependence: escalating dose, craving, running out early, doctor shopping, or using to override sleep/burnout
Abrupt discontinuation after high doses or prolonged use: can cause depression, extreme fatigue, and rebound symptoms

Critical Drug Interactions

Vyvanse is converted to dextroamphetamine. The biggest interaction themes are: MAO inhibitors (dangerous), drugs that increase serotonin (serotonin syndrome risk), and medications that change amphetamine levels or cardiovascular strain.

With: MAO inhibitors (including linezolid or IV methylene blue)

Risk: CONTRAINDICATED: Risk of hypertensive crisis and serious reactions.

Action: Do not use with MAOIs or within 14 days of stopping an MAOI.

With: SSRIs/SNRIs, triptans, lithium, linezolid, other serotonergic agents

Risk: Serotonin syndrome risk (rare, but can be life-threatening).

Action: Use caution, especially with multiple serotonergic meds. Educate on early symptoms (agitation, sweating, diarrhea, tremor, fever) and seek urgent care if they appear.

With: CYP2D6 inhibitors (can raise dextroamphetamine exposure in some patients)

Risk: Higher stimulant exposure may increase side effects (jitteriness, insomnia, BP/HR increases).

Action: Monitor closely after starting or changing interacting meds; dose adjustment may be needed.

With: Other stimulants (including high-dose caffeine, decongestants like pseudoephedrine, or illicit stimulants)

Risk: Additive stimulation: anxiety, insomnia, palpitations, BP/HR increases.

Action: Avoid stacking stimulants. If you’re getting chest symptoms or panic-y jitter, scale back and reassess.

With: Antihypertensives

Risk: Stimulants can blunt blood pressure control in some people.

Action: Monitor BP/HR; adjust treatment plan if blood pressure becomes difficult to manage.

With: Alcohol

Risk: Increased impairment risk and poor judgment; may mask intoxication or worsen risky behavior in some people.

Action: If you drink, keep it conservative and pay attention to how your body reacts. If alcohol worsens impulsivity or sleep, it’s not a good mix.

Pregnancy, Breastfeeding, Special Groups

Vyvanse has specific considerations in pregnancy, breastfeeding, pediatrics, older adults, and kidney disease. The decision is individualized and should include a clear risk/benefit conversation—not just “yes” or “no.”

👶Pregnancy

Human outcome data are limited. Amphetamine exposure in pregnancy may be associated with risks like premature birth and low birth weight, and newborns may have withdrawal-like symptoms (agitation, irritability, excessive drowsiness, feeding difficulties). Nonmedication approaches are preferred for mild to moderate ADHD during pregnancy; for moderate to severe impairment, shared decision-making is key, using the lowest effective dose and the fewest medications possible. Consider enrollment in the National Pregnancy Registry for ADHD Medications (1-866-961-2388).

🤱Breastfeeding

Lisdexamfetamine converts to dextroamphetamine, which can be present in breast milk. Reported relative infant doses (RID) across amphetamine/dextroamphetamine sources have ranged roughly 2% to 13.8% of the weight-adjusted maternal dose, and long-term neurodevelopmental outcomes are not well established. The manufacturer recommends avoiding breastfeeding due to potential serious adverse reactions (including cardiovascular effects and growth suppression). If used during breastfeeding in carefully selected cases, use the lowest effective dose and monitor the infant for feeding problems, irritability, insomnia, or excessive sleepiness.

👧Children & Adolescents (Under 18)

FDA-approved for ADHD in ages 6+ (not recommended under 6). Typical starting dose is 20 to 30 mg once daily in the morning, with increases by 10 mg/day or 20 mg/day every 3 to 7 days until optimal response; max 70 mg/day. Monitor appetite, weight, height/growth velocity, sleep, mood/behavior, and tics.

👴Older Adults (65+)

Use caution. Older adults can be more sensitive to stimulant adverse effects (BP/HR increases, insomnia, anxiety, appetite/weight loss). Start low, titrate slowly, and monitor cardiovascular status closely.

🔬Liver Impairment

No manufacturer dose adjustment provided.

💧Kidney Impairment

Dose caps apply in moderate to severe renal impairment: max 50 mg/day at GFR 15 to <30; max 30 mg/day at GFR <15 or ESRD on hemodialysis.

Clinical Monitoring

Baseline cardiovascular screen: personal and family history of sudden death, ventricular arrhythmia, structural heart disease; physical exam; ECG if indicated or if symptoms/risk factors suggest
Blood pressure and heart rate: baseline, after dose increases, and periodically during treatment
Sleep: insomnia, delayed sleep phase, rebound sleepiness, and whether timing is appropriate
Appetite and weight: baseline and ongoing (children: height/weight/growth velocity; adults: weight and nutritional status)
Mood and behavior: irritability, anxiety, agitation, depressive symptoms, emotional blunting, and functional outcomes
Psychosis/mania screening and monitoring: especially if personal/family history of bipolar disorder, psychosis, or prior stimulant-induced symptoms
Tics/Tourette’s: screen before starting; monitor for new or worsening tics
Peripheral vasculopathy: finger/toe color change, numbness, pain, sores—evaluate if present
Misuse/diversion risk: assess before prescribing; monitor for early refills, dose escalation, lost prescriptions, multiple prescribers, and functional red flags
Binge eating outcomes (if treating BED): binge frequency, loss-of-control eating, impairment, and whether benefit is meaningful; stop if it’s not working

How Well It Works

Vyvanse is often effective when ADHD symptoms look like distractibility, procrastination, impulsive decisions, and inconsistent follow-through. For binge eating disorder, the target is fewer binge episodes and less loss-of-control eating—not weight loss. If you’re not seeing meaningful functional improvement after a careful titration, that’s a reason to reassess the dose, timing, diagnosis, sleep, anxiety, depression, substance use, and overall treatment plan.

Source:

Mechanism of Action

Vyvanse is a prodrug—your body converts it to dextroamphetamine. The active medication increases dopamine and norepinephrine signaling in brain circuits involved in attention, impulse control, and reward. In plain terms: it helps the “focus and brakes” system work more reliably, so you can choose and sustain a task instead of being yanked around by distractions or impulses.

Place in Treatment Algorithm

For ADHD, stimulants are often first-line when symptoms cause real impairment, alongside skills-based supports (sleep, routines, coaching/therapy, workplace/school accommodations). Vyvanse is a good fit when you want once-daily coverage and a smoother day. For binge eating disorder in adults, it’s an evidence-based option for moderate to severe illness, but it’s not a substitute for therapy, nutrition support, and addressing shame/avoidance cycles. Vyvanse is usually a poor choice if uncontrolled anxiety, insomnia, active substance misuse, or untreated bipolar disorder are the main issues—because stimulants can pour gasoline on those problems.

Questions people ask

What is Vyvanse used for?

Vyvanse is used to treat ADHD (in adults and in kids ages 6+) and moderate-to-severe binge eating disorder in adults. For ADHD, it targets attention, impulsivity, and follow-through. For binge eating, the goal is fewer binge episodes and less loss-of-control eating—not weight loss.

How long does Vyvanse take to work, and how long does it last?

Many people notice effects within about 1–2 hours after a morning dose. It commonly lasts 8–14 hours. If you take it too late in the day, insomnia is much more likely.

Is Vyvanse a controlled substance?

Yes. Vyvanse is a Schedule II medication. That means it has a higher potential for misuse and dependence, so prescribing and monitoring are stricter.

What’s the typical adult dose for ADHD?

A common starting dose is 30 mg once daily in the morning. Dose can be increased by 10 mg or 20 mg weekly based on response and side effects. The maximum dose is 70 mg/day.

What’s the typical adult dose for binge eating disorder?

A common starting dose is 30 mg once daily in the morning, with weekly increases by 20 mg toward a target of 50–70 mg once daily (maximum 70 mg/day). If binge eating doesn’t improve, it should be discontinued.

Can Vyvanse help with anxiety or insomnia?

Usually not. Stimulants can worsen anxiety and insomnia, especially if the dose is too high, caffeine is stacking, or sleep is already fragile. If your main problem is anxiety or sleep, Vyvanse is often the wrong tool.

What are the most common Vyvanse side effects?

The most common are decreased appetite, insomnia, dry mouth, jitteriness/restlessness, irritability, and nausea or constipation/diarrhea. Heart rate and blood pressure can also increase, which is why vitals are monitored.

Can Vyvanse cause psychosis or mania?

It can, especially in people with vulnerability (personal or family history of bipolar disorder or psychosis) or at higher doses. Warning signs include paranoia, hallucinations, delusional thinking, or feeling ramped into mania. If that happens, stop and contact your prescriber urgently.

Do I need an ECG before starting Vyvanse?

Not always. What matters most is a careful cardiovascular history (including family history of sudden cardiac death or arrhythmias) and a physical exam. An ECG isn’t mandatory for everyone, but it can be reasonable if there are symptoms, risk factors, or clinical concern.

Can I stop Vyvanse suddenly?

Many people can stop without a long taper, but stopping abruptly after high doses or long-term use can cause a crash—fatigue, low mood, irritability, and rebound ADHD symptoms. If you’re stopping because of severe side effects (like mania/psychosis or serious heart symptoms), get urgent medical guidance.

What’s the biggest safety mistake people make with Vyvanse?

Taking it too late (hello insomnia), skipping meals (then getting shaky/irritable and sleeping worse), stacking stimulants (like high caffeine or decongestants), or using it to override burnout. The medication should support a stable life—not replace sleep, food, and limits.

Are there dose limits with kidney disease?

Yes. In adults with GFR 15 to <30 mL/min/1.73 m2, the max is 50 mg/day. With GFR <15 or ESRD on hemodialysis, the max is 30 mg/day. In GFR ≥30, the manufacturer doesn’t provide a specific adjustment.